U.S. Influenza Diagnostics Market Size & Outlook
U.S. influenza diagnostics market, 2018-2030 (US$M)
Related Markets
U.S. influenza diagnostics market highlights
- The U.S. influenza diagnostics market generated a revenue of USD 472.3 million in 2023 and is expected to reach USD 662.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
- In terms of segment, ridt was the largest revenue generating test type in 2023.
- RIDT is the most lucrative test type segment registering the fastest growth during the forecast period.
Influenza diagnostics market data book summary
| Market revenue in 2023 | USD 472.3 million |
| Market revenue in 2030 | USD 662.2 million |
| Growth rate | 4.9% (CAGR from 2023 to 2030) |
| Largest segment | Ridt |
| Fastest growing segment | RIDT |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | RIDT, RT-PCR, Cell Culture |
| Key market players worldwide | 3M Co, Abbott Laboratories, Becton Dickinson & Co, Meridian Bioscience, QuidelOrtho Corp, Roche Holding AG, Sekisui Chemical Co Ltd, Thermo Fisher Scientific Inc, Hologic Inc, SA Scientific |
Other key industry trends
- In terms of revenue, U.S. accounted for 28.9% of the global influenza diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. influenza diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 86.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Influenza Diagnostics Market Scope
Influenza Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. influenza diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to influenza diagnostics market will help companies and investors design strategic landscapes.
Ridt was the largest segment with a revenue share of 30.91% in 2023. Horizon Databook has segmented the U.S. influenza diagnostics market based on ridt, rt-pcr, cell culture covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Influenza Diagnostics Test Type Outlook (Revenue, USD Million, 2018-2030)
- RIDT
- RT-PCR
- Cell Culture
- Others
- U.S. Influenza Diagnostics End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- POCT
- Laboratories
Reasons to subscribe to U.S. influenza diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. influenza diagnostics market databook
-
Our clientele includes a mix of influenza diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. influenza diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. influenza diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. influenza diagnostics market size, by test type, 2018-2030 (US$M)
U.S. Influenza Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
